Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

CompletedOBSERVATIONAL
Enrollment

2,288

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
HIV-1 Patients
Trial Locations (103)

1000

Site Ref # / Investigator 6199, Ljubljana

15540

Site Ref # / Investigator 6190, Bialystok

31096

Site Ref # / Investigator 57048, Haifa

40011

Site Ref # / Investigator 57053, Ústí nad Labem

44281

Site Ref # / Investigator 6124, Kfar Saba

49115

Site Ref # / Investigator 57042, Dnipro

50005

Site Ref # / Investigator 57055, Hradec Králové

54003

Site Ref # / Investigator 57044, Mykolaiv

57107

Site Ref #/Investigator 57107, Kirov

76100

Site Ref # / Investigator 57047, Rehovot

83045

Site Ref # / Investigator 57043, Donetsk

84101

Site Ref # / Investigator 57050, Beersheba

91120

Site Ref # / Investigator 57049, Jerusalem

95006

Site Ref # / Investigator 57040, Simferopol

105275

Site Ref # / Investigator 56904, Moscow

Site Ref # / Investigator 6209, Moscow

129110

Site Ref # / Investigator 56902, Moscow

150000

Site Ref # / Investigator 57026, Yaroslavl

153000

Site Ref # / Investigator 57028, Ivanovo

156007

Site Ref # / Investigator 57030, Kostroma

160002

Site Ref #/Investigator 57103, Vologda

170024

Site Ref # / Investigator 56947, Tver'

Site Ref # / Investigator 57035, Tver'

183047

Site Ref # / Investigator 57024, Murmansk

190000

Site Ref # / Investigator 57033, Saint Petersburg

190103

Site Ref # / Investigator 56906, Saint Petersburg

191167

Site Ref # / Investigator 56905, Saint Petersburg

196645

Site Ref # / Investigator 56920, Saint Petersburg

Site Ref # / Investigator 57038, Saint Petersburg

200515

Site Ref # / Investigator 57067, Craiova

300002

Site Ref # / Investigator 57034, Tula

300310

Site Ref # / Investigator 57066, Timișoara

344006

Site Ref # / Investigator 56911, Rostov-on-Don

350015

Site Ref # / Investigator 56943, Krasnodar

Site Ref # / Investigator 56944, Magnitogorsk

398043

Site Ref # / Investigator 57025, Lipetsk

400040

Site Ref # / Investigator 56916, Volgograd

410009

Site Ref # / Investigator 56913, Saratov

420000

Site Ref # / Investigator 56909, Kazan'

426067

Site Ref # / Investigator 57036, Izhevsk

432071

Site Ref # / Investigator 56914, Ulyanovsk

443041

Site Ref # / Investigator 56931, Samara

445846

Site Ref # / Investigator 56962, Tolyatti

450077

Site Ref # / Investigator 57029, Ufa

454052

Site Ref # / Investigator 56918, Chelyabinsk

460035

Site Ref # / Investigator 56915, Orenburg

Site Ref # / Investigator 57031, Orenburg

500174

Site Ref # / Investigator 57064, Brasov

540394

Site Ref # / Investigator 57065, Târgu Mureş

565031

Site Ref # / Investigator 57039, Odesa

600023

Site Ref # / Investigator 57027, Vladimir

603005

Site Ref # / Investigator 56907, Nizhny Novgorod

614000

Site Ref # / Investigator 56930, Perm

620102

Site Ref # / Investigator 56923, Yekaterinburg

620115

Site Ref # / Investigator 56903, Yekaterinburg

628002

Site Ref # / Investigator 56932, Khanty-Mansiysk

628400

Site Ref # / Investigator 56908, Surgut

628602

Site Ref # / Investigator 56910, Tyumen

Site Ref # / Investigator 56919, Tyumen

629806

Site Ref # / Investigator 56926, Noyabrsk

630000

Site Ref # / Investigator 56942, Novosibirsk

640007

Site Ref # / Investigator 57021, Kurgan

650056

Site Ref # / Investigator 57037, Kemerovo

Site Ref #/Investigator 57105, Kemerovo

654031

Site Ref # / Investigator 56929, Novokuznetsk

658610

Site Ref # / Investigator 57022, Barnaul

660049

Site Ref # / Investigator 56928, Krasnoyarsk

Site Ref #/Investigator 57106, Krasnoyarsk

663318

Site Ref # / Investigator 56964, Noril'sk

664043

Site Ref # / Investigator 56921, Irkutsk

Site Ref #/Investigator 57104, Irkutsk

670034

Site Ref # / Investigator 56949, Ulan-Ude

672000

Site Ref # / Investigator 56963, Chita

677004

Site Ref # / Investigator 56946, Yakutsk

680029

Site Ref # / Investigator 56948, Khabarovsk

700116

Site Ref # / Investigator 57068, Iași

900708

Site Ref # / Investigator 57063, Constanța

2360000

Site Ref # / Investigator 56945, Kaliningrad

639 00

Site Ref # / Investigator 57102, Brno

370 87

Site Ref # / Investigator 57054, České Budějovice

708 52

Site Ref # / Investigator 57056, Ostrava

305 99

Site Ref # / Investigator 57052, Pilsen

180 01

Site Ref # / Investigator 5344, Prague

Unknown

Site Ref # / Investigator 7576, Tbilisi

Site Ref # / Investigator 57051, Tel Litwinsky

Site Ref # / Investigator 7578, Riga

LT-10105

Site Ref # / Investigator 6127, Vilnius

85-030

Site Ref # / Investigator 56885, Bydgoszcz

41-500

Site Ref # / Investigator 56887, Chorzów

80-214

Site Ref # / Investigator 56883, Gdansk

31-531

Site Ref # / Investigator 56888, Krakow

91-347

Site Ref # / Investigator 56889, Lodz

61-285

Site Ref # / Investigator 56884, Poznan

71-455

Site Ref # / Investigator 56886, Szczecin

01-201

Site Ref # / Investigator 56882, Warsaw

51-149

Site Ref # / Investigator 56890, Wroclaw

021105

Site Ref # / Investigator 6194, Bucharest

030303

Site Ref # / Investigator 57062, Bucharest

11 000

Site Ref # / Investigator 7579, Belgrade

813 69

Site Ref # / Investigator 6208, Bratislava

01015

Site Ref # / Investigator 57045, Kyiv

Site Ref # / Investigator 6191, Kyiv

03115

Site Ref # / Investigator 57046, Kyiv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY

NCT01379703 - Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use | Biotech Hunter | Biotech Hunter